Literature DB >> 1562463

Suppression of properties associated with malignancy in murine melanoma-melanocyte hybrid cells.

W F Wakeling1, J Greetham, L M Devlin, D C Bennett.   

Abstract

Murine and human melanoma cells differ relatively reliably from non-tumorigenic melanocytes in certain biological properties. When cultured at low pH, melanocytes tend to be pigmented and melanoma cells unpigmented. The growth of virtually all metastatic melanoma cells is inhibited by phorbol esters such as TPA (12-O-tetradecanoyl phorbol-13-acetate), which stimulate melanocyte growth. Melanocytes fail to grow in suspension culture or produce tumours when implanted in animals, while many melanoma lines can do both. Here we studied which of these properties were dominant in hybrid cells formed by fusion of drug-resistant murine B16-F10RR melanoma cells to melanocytes of the albino and brown lines, melan-c and melan-b. The albino melanocytes are unpigmented but well-differentiated, the brown melanocytes produce pale brown pigment and the melanoma cells are unpigmented under the conditions used. All hybrid colonies observed produced black pigment, except some melan-b/melanoma hybrids when growing sparsely with TPA. Thus pigmentation was generally dominant. 14/15 hybrid lines showed stimulation of proliferation by TPA, as do melanocytes. Most hybrid lines showed no or reduced capacity for growth in suspension, though some grew better in suspension when TPA was present. There was marked suppression of the tumorigenicity of the parental melanoma cells in 4/8 hybrids examined, and tumorigenicity was reduced in the others, despite considerable chromosome loss by the passage level tested. Thus most properties of the non-tumorigenic pigment cells were dominant, as often observed for other cell lineages, and providing further evidence for gene loss in the genesis of malignant melanoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1562463      PMCID: PMC1977561          DOI: 10.1038/bjc.1992.110

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  37 in total

1.  SELECTION OF HYBRIDS FROM MATINGS OF FIBROBLASTS IN VITRO AND THEIR PRESUMED RECOMBINANTS.

Authors:  J W LITTLEFIELD
Journal:  Science       Date:  1964-08-14       Impact factor: 47.728

2.  Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p.

Authors:  S J Bale; N C Dracopoli; M A Tucker; W H Clark; M C Fraser; B Z Stanger; P Green; H Donis-Keller; D E Housman; M H Greene
Journal:  N Engl J Med       Date:  1989-05-25       Impact factor: 91.245

3.  A mathematical model for the age distribution of cancer in man.

Authors:  P J Cook; R Doll; S A Fellingham
Journal:  Int J Cancer       Date:  1969-01-15       Impact factor: 7.396

4.  Hygromycin B phosphotransferase as a selectable marker for DNA transfer experiments with higher eucaryotic cells.

Authors:  K Blochlinger; H Diggelmann
Journal:  Mol Cell Biol       Date:  1984-12       Impact factor: 4.272

5.  Establishment of a mouse melanocyte clone which synthesizes both eumelanin and pheomelanin.

Authors:  C Sato; S Ito; T Takeuchi
Journal:  Cell Struct Funct       Date:  1985-12       Impact factor: 2.212

6.  Gene dosage dependence of pigment synthesis in melanoma x fibroblast hybrids (hamster cells-mouse fibroblast-DOPA-oxidase-irradiation).

Authors:  C Fougère; F Ruiz; B Ephrussi
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

7.  Mutations in the p53 gene occur in diverse human tumour types.

Authors:  J M Nigro; S J Baker; A C Preisinger; J M Jessup; R Hostetter; K Cleary; S H Bigner; N Davidson; S Baylin; P Devilee
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

8.  Increased experimental metastatic capacity of a murine melanoma following induction of differentiation.

Authors:  D C Bennett; T J Dexter; E J Ormerod; I R Hart
Journal:  Cancer Res       Date:  1986-07       Impact factor: 12.701

9.  Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells.

Authors:  H J Huang; J K Yee; J Y Shew; P L Chen; R Bookstein; T Friedmann; E Y Lee; W H Lee
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

10.  Phenotypic heterogeneity of melanoma. Relation to the differentiation program of melanoma cells.

Authors:  A N Houghton; F X Real; L J Davis; C Cordon-Cardo; L J Old
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Generation of Cancer Stem/Initiating Cells by Cell-Cell Fusion.

Authors:  Thomas Dittmar
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

2.  Melanoma x macrophage hybrids with enhanced metastatic potential.

Authors:  M Rachkovsky; S Sodi; A Chakraborty; Y Avissar; J Bolognia; J M McNiff; J Platt; D Bermudes; J Pawelek
Journal:  Clin Exp Metastasis       Date:  1998-05       Impact factor: 5.150

3.  Experimental metastasis and differentiation of murine melanoma cells: actions and interactions of factors affecting different intracellular signalling pathways.

Authors:  D C Bennett; A Holmes; L Devlin; I R Hart
Journal:  Clin Exp Metastasis       Date:  1994-11       Impact factor: 5.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.